Compass Therapeutics | Investor Presentation Deck | 23 slides

Compass Therapeutics · 2022-05
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

23
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
establish_context
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The slide is divided into Senior Executive Team (CEO, COO, CSO, CMC, VPs) and Board of Directors.other
Open slide detailBeat · TeamLoop · Cost Of Inaction
05
The slide uses a Gantt-style layout to track clinical phases and regulatory milestones.plan_implementation
Open slide detailLoop · Cost Of Inaction
06
transition
Open slide detailLoop · Cost Of Inaction
07
inspire_vision
Open slide detailBeat · SolutionLoop · Cost Of Inaction
08
The slide presents key clinical trial results for a drug candidate, focusing on response rates.show_traction
Open slide detailBeat · ProductLoop · Cost Of Inaction
09
Uses the Simon 2-Stage adaptive design framework.present_framework
Open slide detailBeat · ProductLoop · Cost Of Inaction
10
The slide highlights a specific row (2 prior systemic therapies) with a red box.analyze_data
Open slide detailBeat · ProductLoop · Cost Of Inaction
11
The chart uses a standard oncology waterfall plot format to visualize tumor shrinkage.show_traction
Open slide detailBeat · ProductLoop · Cost Of Inaction
12
Standard clinical trial swimmer plot showing treatment duration, response (PR/SD), progression (PD), death, and ongoing status.analyze_data
Open slide detailBeat · ProductLoop · Cost Of Inaction
13
analyze_data
Open slide detailLoop · Cost Of Inaction
14
plan_implementation
Open slide detailLoop · Cost Of Inaction
15
Includes comparative data against FOLFOX and TOPAZ-1.show_traction
Open slide detailLoop · Cost Of Inaction
16
transition
Open slide detailLoop · Cost Of Inaction
17
Includes a molecular visualization of the antibody-receptor interaction.present_solution
Open slide detailLoop · Cost Of Inaction
18
The slide uses medical imaging (CT scans) to demonstrate treatment efficacy.illustrate_case
Open slide detailLoop · Cost Of Inaction
19
plan_implementation
Open slide detailLoop · Cost Of Inaction
20
transition
Open slide detailLoop · Cost Of Inaction
21
The slide uses a process flow to show the transition from testing a hypothesis to the identification of the lead candidate CTX-8371, supported by two experimentpresent_solution
Open slide detailLoop · Cost Of Inaction
22
plan_implementation
Open slide detailLoop · Cost Of Inaction
23
The slide uses a visual legend (checkmarks for completed, stars for in-progress) to track status of specific drug development milestones.plan_implementation
Open slide detailLoop · Cost Of Inaction